Arcade Therapeutics
PrivateLast Round
Crowdfunding
Aug 6, 2024
Est. Valuation
$12.5M
Total Funding Raised
$7.33M
Company Overview
Arcade Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in July 2023.
Arcade Therapeutics is a healthcare technology company that develops prescription digital therapeutics in the form of mobile games to treat mental health conditions such as anxiety and depression.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Gaming, Patient Engagement
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arcade Therapeutics Comparables
Compare Arcade Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepWell DTx | 82% | |
| DarioHealth Corp. | 77% | |
| Alex Therapeutics | 77% |
For institutional investors. Book with your work email.
Arcade Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 6, 2024 | ||||
| Grant | Jul 26, 2023 | ||||
| Pre Seed | Feb 17, 2023 | ||||
| Seed Round | Aug 1, 2022 | ||||
| Seed | Jun 30, 2022 | ||||
Pre Seed | Oct 8, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arcade Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3LS Ventures | Seed, Pre Seed |
| National Institute of Mental Health | Grant |
| Teem Ventures | Seed, Pre Seed |
| BAT VC | Seed, Pre Seed |
| NIH RADx | Grant |
| Blu Venture Investors | Seed, Pre Seed |
| StartUp Health | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2023
$4M grant from National Institute of Mental Health and NIH.
For institutional investors. Book with your work email.
Arcade Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arcade Therapeutics's valuation, stock price, and market status.
Is Arcade Therapeutics a public or private company?
Arcade Therapeutics is a private company.
What is the current stock price of Arcade Therapeutics?
Arcade Therapeutics is a private company, so its shares have no public market price. Caplight tracks Arcade Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arcade Therapeutics worth (valuation)?
Arcade Therapeutics's valuation is estimated at $12.5M based on funding round data.
Can I buy Arcade Therapeutics stock?
Arcade Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arcade Therapeutics's last funding round?
Arcade Therapeutics's most recent funding round was Crowdfunding on August 6, 2024.
Who are the main investors in Arcade Therapeutics?
Key investors in Arcade Therapeutics include BAT VC, SeedLink Ventures.
Will Arcade Therapeutics IPO soon?
No public IPO plans have been announced for Arcade Therapeutics.
How can I track Arcade Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Arcade Therapeutics's shares on secondary markets.